FDA inspection
Cipla Limited: FDA inspection ending Sep 27, 2019
FDA inspection 1103305 · Official Action Indicated (OAI) · Salcette
Key facts
| Inspection ID | 1103305 |
|---|---|
| Firm | Cipla Limited |
| FEI number | 3004081307 |
| Address | L129 - 146 S - 103 - 105 S - 107 - 112 L147 - L147 1 |
| City | Salcette |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Sep 27, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 597511 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data